Paragraph 5A Updating of information about or relating to a superintendentF1
Where, in the case of a body corporate making an application for inclusion in a pharmaceutical list, there is a change to the superintendent of the body corporate before the applicant is included in a pharmaceutical list or the application cannot be further proceeded with, the applicant must update the application as soon as is reasonably practicable with—
the details about that superintendent that the applicant would have been required to submit under paragraph 3; and
the details about any other body corporate that the applicant would have been required to submit under paragraph 4 because of that superintendent being that other body corporate’s superintendent,
had the superintendent been in post at the time the application was submitted.
If—
the application has been determined by NHS England but—
there are proceedings relating to the application that have not yet reached their final outcome, or
in the case of an application that has been granted, there are no such proceedings but the applicant has not yet been included in a pharmaceutical list; and
NHS England is satisfied, on the basis of the information provided or required to be provided under sub-paragraph (1), that there are grounds for refusing the application under regulation 33 or imposing a condition under regulation 35,
NHS England may redetermine the application, but only for the purpose of refusing it under regulation 33 or imposing a condition under regulation 35 (so there may still be a purpose to any proceedings that have not yet reached their final outcome).